25 results
8-K
EX-99.1
3pyts qhot
14 Nov 22
NexImmune Reports Third Quarter 2022 Financial Results and Announces Strategic Update
4:11pm
8-K
EX-99.1
pva1om8o05yiu588v1cd
15 Aug 22
NexImmune Reports Second Quarter 2022 Financial Results and Highlights FDA Clearance of IND for NEXI-003 for the Treatment of HPV-Related Cancers
4:28pm
10-Q
drylaz
17 May 21
Quarterly report
4:14pm
8-K
EX-99.1
9todu47ktddks
17 May 21
NexImmune Reports First Quarter 2021
4:10pm
8-K
EX-99.1
tepx3anqo zan7
31 Mar 21
NexImmune Reports Fiscal Year 2020 Financial Results and Recent Updates
5:20pm
10-K
1y2ww6xny0nh83pfsv5
31 Mar 21
Annual report
4:02pm
424B4
ohmd3 n8ykc8g
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
xjxn8gy
8 Feb 21
IPO registration (amended)
7:29am
S-1/A
EX-10.2.1
fby7sc
8 Feb 21
IPO registration (amended)
7:29am